Dr Reddy's launches cancer treatment injection Bortezomib in US


PTI | New Delhi | Updated: 27-07-2022 11:10 IST | Created: 27-07-2022 11:08 IST
Dr Reddy's launches cancer treatment injection Bortezomib in US
Representative image
  • Country:
  • India

Dr Reddy's Laboratories on Wednesday said it has launched Bortezomib for Injection, used to treat certain types of cancer, in the US market.

The Hyderabad-based drug major launched the product after getting approval from the US Food and Drug Administration (USFDA).

The company's product is the generic version of the Velcade brand.

According to IQVIA Health, Velcade and other generics have sales of around USD 1.2 billion in the US.

Dr Reddy's Bortezomib for Injection is supplied in a 3.5 mg per 10 mL single-dose vial presentation for subcutaneous (SQ) or intravenous (IV) use, it noted.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback